Maharashtra FDA Seizes Rs 1.39 Crore in Health Supplements Amid Crackdown
The Maharashtra Food and Drug Administration (FDA) has issued a stringent statewide compliance order targeting the health supplement industry following a coordinated raid that seized stock worth Rs 1.39 crore. The crackdown targets manufacturers, pharmacies, gyms, and online sellers for using unapproved ingredients and making misleading disease-cure claims.
The Maharashtra Food and Drug Administration (FDA) has issued a comprehensive statewide compliance order tightening regulations on the sale and manufacture of health supplements, nutraceuticals, and special dietary foods. The directive follows a coordinated inspection drive that resulted in the seizure of stock valued at Rs 1.39 crore from 17 establishments across six divisions.
The order, issued by Food Safety Commissioner Tukaram Mundhe on Friday, mandates immediate adherence to stricter rules for manufacturers, contract manufacturers, brand owners, importers, distributors, warehouses, retailers, pharmacies, medical stores, gyms, fitness centers, hospital suppliers, and e-commerce entities operating within the state.
During the inspection drive conducted on November 13, FDA officials discovered that certain products contained two specific ingredients—Magnesium Acetyl Taurate and Nicotinamide Mononucleotide—for which the Food Safety and Standards Authority of India (FSSAI) had previously rejected approval applications. The FDA stated that manufacturers had utilized these ingredients without obtaining necessary product approvals, while marketers sold them without the relevant food category being endorsed on their licenses.
The new regulations apply with immediate effect across all sectors of the supply chain. Pharmacies, medical stores, and gyms are now required to obtain a valid FSSAI food license or registration specifically to sell health supplements and nutraceuticals, even if they already hold licenses under other laws. The relevant food category must be explicitly endorsed on these licenses.
The FDA has strictly prohibited claims that any supplement can treat, cure, mitigate, or prevent diseases. Representations suggesting that products are "recommended by doctors" or "nutritionists," as well as the use of photographs of physicians or claims of clinical prescription, are banned. These restrictions extend to all forms of advertising, including print media, television, websites, mobile applications, e-commerce listings, and social media platforms, including paid influencer promotions.
Businesses have been directed to preserve all advertising material for a period of three years. Additionally, the use of the term "ORS" in a product’s name, brand name, or trademark is prohibited. Product labels must prominently display the words "NOT FOR MEDICINAL USE" in bold capital letters, along with the correct food category, ingredients, recommended dosage, prescribed warnings, and other mandatory declarations.
The order also clarified botanical ingredient requirements, stating that only roots and root extracts of Ashwagandha are permitted. The specific plant part used must be declared for every botanical ingredient alongside prescribed warnings.
Seizure data from the November 13 operation highlights the scale of the enforcement effort. Nagpur recorded the highest seizure, with officials confiscating stock worth Rs 57.30 lakh after inspecting four establishments. In the Konkan division, which includes the Thane region, one establishment was inspected, resulting in the seizure of stock worth Rs 47.65 lakh. Pune saw five establishments inspected with Rs 30.57 lakh seized, while Nashik officials inspected five locations and seized Rs 19.9 lakh. In Chhatrapati Sambhajinagar, one establishment was inspected with Rs 14.2 lakh seized. No seizures were reported in Amravati despite an inspection.
The seized products have been placed in safe custody, and samples have been sent to laboratories for analysis to determine if they are substandard, unsafe, or misbranded. Further action will be taken based on the reports from Food Analysts.
Under the new order, officials are directed to prioritize the scrutiny of sports nutrition, weight-loss, sexual wellness, herbal, and imported products, as well as food for special medical purposes and products sold online. Samples suspected of containing undeclared steroids, hormones, or drug substances will be tested at notified laboratories using validated methods. Online surveillance and test purchases will also be employed to identify violations.
Specific technical standards have been established: vitamins and minerals must not exceed prescribed limits or one Recommended Dietary Allowance (RDA) for Indians. Products for children between two and five years of age can only be administered on the advice of a physician, dietitian, or nutritionist. Food for sportspersons must not contain substances prohibited by the World Anti-Doping Agency (WADA), and probiotic products must contain at least 10 CFU in the daily serving.
Food for special medical purposes must be used under medical supervision and carry prescribed warnings. Such products cannot be presented in tablet, capsule, gummy, jelly, or strip form.
The FDA reported that 1,100 food business licenses are currently operational in Maharashtra under the health supplement and nutraceutical categories. This includes 313 manufacturers, 759 relabelers, and 28 repackers. All will be covered by risk-based inspections under the new order.
Businesses have been directed to stop the storage, distribution, and sale of food products containing unapproved ingredients or those with rejected approval applications. Manufacturers must maintain quality control records and ensure traceability. If a product is found unsafe, a recall must be initiated immediately, with the Food Authority and Commissioner of Food Safety informed within 24 hours. Serious adverse effects must be reported to the Designated Officer within 48 hours.
Violations can result in improvement notices, seizure of products, recalls, suspension or cancellation of licenses, financial penalties, and prosecution. Misleading advertisements can attract penalties of up to Rs 10 lakh, as can operating a food business without a license. Under Section 59 of the Food Safety and Standards Act, selling unsafe food can lead to imprisonment. Punishments range from three months for violations causing no injury, one year for non-grievous injury, and six years for grievous injury. If consumption results in death, the punishment ranges from a minimum of seven years imprisonment to life imprisonment, along with a fine of at least Rs 10 lakh.
The FDA has urged consumers to purchase supplements only from licensed outlets and trusted online sellers. Consumers are advised to obtain bills, check FSSAI license numbers, verify ingredients, dosage instructions, batch numbers, expiry dates, and warnings. They have been warned against products promising rapid weight loss, instant muscle gain, or cures for diabetes and high blood pressure.
Suspicious product labels or advertisements can be reported through the FDA’s toll-free number 1800222365 or its grievance portal at complaintsmahafdain. The department has assured that the identity of complainants will be kept confidential.
M.Anderson--SMC